Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001053307 | SCV001217565 | pathogenic | PTEN hamartoma tumor syndrome | 2019-12-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val275*) in the PTEN gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with PTEN-related conditions. Loss-of-function variants in PTEN are known to be pathogenic (PMID: 9467011, 21194675). For these reasons, this variant has been classified as Pathogenic. |
Juno Genomics, |
RCV004796358 | SCV005417219 | likely pathogenic | Macrocephaly-autism syndrome; Familial meningioma; Glioma susceptibility 2; Familial prostate cancer; Cowden syndrome 1 | criteria provided, single submitter | clinical testing | PM2_Supporting+PVS1 |